WordNet

the way in which someone or something is composed (同)composition, physical composition, makeup, make-up
the act of forming or establishing something; "the constitution of a PTA group last year"; "it was the establishment of his reputation"; "he still remembers the organization of the club" (同)establishment, formation, organization, organisation
sanctioned by or consistent with or operating under the law determining the fundamental political principles of a government; "the constitutional right of free speech"; "constitutional government"; "constitutional guarantees"
a regular walk taken as a form of exercise
of benefit to or intended to benefit your physical makeup; "constitutional walk"
the use of chemical agents to treat or control disease (or mental illness)

PrepTutorEJDIC

〈U〉(物の)『構成』,構造《+『of』+『名』》 / 〈C〉〈U〉『体格』,体質,性分質,気質 / 〈C〉政体 / 〈C〉『憲法』,国憲 / 《the C-》合衆国憲法 / 〈U〉(制度などの)制定…(機関なとの)設立
体質の,生まれつきの;構成上の / 憲法の,立憲の / 《話》健康のための散歩
化学療法

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 非プラチナ製剤ベースの癌化学療法の神経学的合併症の概要 overview of neurologic complications of non platinum cancer chemotherapy
2. プラチナベースの化学療法の神経学的合併症の概要 overview of neurologic complications of platinum based chemotherapy
3. 肝疾患を有する患者における化学療法による肝毒性および用量調整 chemotherapy hepatotoxicity and dose modification in patients with liver disease
4. 初期化学療法後の再発古典型ホジキンリンパ腫の治療 treatment of relapse of classical hodgkin lymphoma after initial chemotherapy
5. 早期乳癌に対する補助化学療法の急性副作用 acute side effects of adjuvant chemotherapy for early stage breast cancer

SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.

Schuetze SM1, Wathen JK2, Lucas DR3, Choy E4, Samuels BL5, Staddon AP6, Ganjoo KN7, von Mehren M8, Chow WA9, Loeb DM10, Tawbi HA11, Rushing DA12, Patel SR13, Thomas DG14, Chugh R1, Reinke DK15, Baker LH1.
Cancer.Cancer.2015 Dec 28. doi: 10.1002/cncr.29858. [Epub ahead of print]
BACKGROUND: Dasatinib exhibited activity in preclinical models of sarcoma. The Sarcoma Alliance for Research through Collaboration (SARC) conducted a multicenter, phase 2 trial of dasatinib in patients with advanced sarcoma.METHODS: Patients received dasatinib twice daily. The primary objective was
PMID 26710211

Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800).

Carducci MA1, Manola J2, Nair SG3, Liu G4, Rousey S5, Dutcher JP6, Wilding G7.
Clinical genitourinary cancer.Clin Genitourin Cancer.2015 Dec;13(6):531-539.e1. doi: 10.1016/j.clgc.2015.07.002. Epub 2015 Jul 17.
BACKGROUND: Atrasentan, an oral endothelin receptor A antagonist, demonstrated phase 1 activity in patients with renal cell carcinoma (RCC). A phase 2 study was undertaken in patients with measurable or bone-only metastatic RCC in the pre-VEGF/TKI era.METHODS AND MATERIALS: Patients were stratified
PMID 26272427

Making the Grade: The Impact of Low-Grade Toxicities on Patient Preference for Treatment With Novel Agents.

Castellanos EH1, Chen SC1, Drexler H1, Horn L1.
Journal of the National Comprehensive Cancer Network : JNCCN.J Natl Compr Canc Netw.2015 Dec;13(12):1490-5.
BACKGROUND: Targeted therapies have shown clinical benefit in the treatment of solid tumors. The toxicity profiles and treatment duration and schedule of these agents differ considerably from those of traditional chemotherapy. Many studies of targeted therapies report sizeable numbers of grade 1 or
PMID 26656518

新井康通,佐藤麗子,桂隆志,小松弘一,河田兼光,藤野忠彦,大内基史,薬丸一洋
結核 70(7), 431-437, 1995
… A 49-year-old Japanese male who had been imprisoned for five years then lived withother men complained of fever, constitutional symptoms and a 12 kg weight loss over fourmonth period. … Chest X-ray showed patchy, infiltrative small shadows primarily in the right upper lung field without hilar adenopathy.<BR>Before transfer to our hospital, tuberculosis chemotherapy composed of SM, INH, RFP and PZA was initiated. …
NAID 130001411899

西原龍司
岡山医学会雑誌 97(7-8), 661-676, 1985-08-30
… Results of combination chemotherapy for malignant lymphoma between 1973 and 1982 were analysed. … None of the patients had prior chemotherapy. … Among the chemotherapy effect, stage, constitutional symptoms, serum LDH, C-reactive protein (CRP), lymphocyte count of peripheral blood, and erythrocyte sedimentation rate(ESR), a CRP over 3+ and ESR over 30mm/hr were defined as poor prognostic factors for DM. …
NAID 120002306747

奥村哲,長谷川潤,大原正雄,川村直樹,阿部裕行,由井康雄,金森幸男,吉田和弘,西村泰司,富田勝,秋元成太
泌尿器科紀要 30(12), 1801-1807, 1984-12
… On the average 208 mg of CDDP was given to the patients receiving chemotherapy without antiandrogen therapy (13 patients who showed resistance to hormone and an untreated new patient) and both ADM and IFM were also given to 3 of them. … According to the criterion proposed by Shida and his coworkers, the chemotherapy without antiandrogen therapy was effective in 2 cases, relatively effective in 7 cases, and ineffective in 5 cases. …
NAID 120002158872